Biology of cancer and aging: A complex association with cellular senescence

Journal of Clinical Oncology

Volumn 32, Issue 24, 2014, Pages 2604-2610

  Falandry, Claire ^a   Bonnefoy, Marc ^a   Freyer, Gilles ^a   Gilson, Eric ^b  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CELL AGING; CELL EXTRINSIC MECHANISM; CELL FUNCTION; CELL INTRINSIC MECHANISM; GENE MUTATION; HISTORY OF MEDICINE; HUMAN; LONGEVITY; NEOPLASM; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SENESCENCE; STEM CELL; TELOMERE; THEORY; AGE; GENETICS; PATHOLOGY; PHYSIOLOGY;

AGE FACTORS; AGING; CELL AGING; HUMANS; NEOPLASMS;

EID: 84906230064     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.1432     Document Type: Review

References (78)

1. Muñoz-Espín D, Cañamero M, Maraver A, et al: Programmed cell senescence during mammalian embryonic development. Cell 155:1104-1118, 2013
2. Storer M, Mas A, Robert-Moreno A, et al: Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155:1119-1130, 2013
3. Henshaw PS, Riley EF, Stapleton GE: The biologic effects of pile radiations. Radiology 49:349-360, 1947
4. Failla G: The aging process and cancerogenesis. Ann N Y Acad Sci 71:1124-1140, 1958
5. Szilard L: On the nature of the aging process. Proc Natl Acad Sci U S A 45:30-45, 1959
6. Medawar PB: Unsolved Problems of Biology. London, United Kingdom, H.K. Lewis, 1952
7. Harman D: Aging: A theory based on free radical and radiation chemistry. J Gerontol 11:298-300, 1956
8. Lindner AB, Demarez A: Protein aggregation as a paradigm of aging. Biochim Biophys Acta 1790: 980-996, 2009
9. Aguilaniu H, Gustafsson L, Rigoulet M, et al: Asymmetric inheritance of oxidatively damaged proteins during cytokinesis. Science 299:1751-1753, 2003 (Pubitemid 36337204)
10. Nyström T: A bacterial kind of aging. PLoS Genet 3:e224, 2007
11. Fraga MF, Ballestar E, Paz MF, et al: Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102: 10604-10609, 2005 (Pubitemid 41061601)
12. Imai S, Kitano H: Heterochromatin islands and their dynamic reorganization: A hypothesis for three distinctive features of cellular aging. Exp Gerontol 33:555-570, 1998 (Pubitemid 128370100)
13. Slagboom PE, Vijg J: The dynamics of genome organization and expression during the aging process. Ann N Y Acad Sci 673:58-69, 1992 (Pubitemid 23057560)
14. Welch JS, Ley TJ, Link DC, et al: The origin and evolution of mutations in acute myeloid leukemia. Cell 150:264-278, 2012
15. Chao MP, Weissman IL, Majeti R: The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol 24:225-232, 2013
16. Campisi J: Cancer and ageing: Rival demons? Nat Rev Cancer 3:339-349, 2003 (Pubitemid 37328854)
17. Cheng WH, Muftic D, Muftuoglu M, et al: WRN is required for ATM activation and the S-phase checkpoint in response to interstrand cross-linkinduced DNA double-strand breaks. Mol Biol Cell 19:3923-3933, 2008
18. Pereira S, Bourgeois P, Navarro C, et al: HGPS and related premature aging disorders: From genomic identification to the first therapeutic approaches. Mech Ageing Dev 129:449-459, 2008
19. Williams GC: Pleiotropy, natural selection, and the evolution of senescence. Evolution 11:398-411, 1957
20. Campisi J: Cellular senescence as a tumorsuppressor mechanism. Trends Cell Biol 11:S27-S31, 2001
21. Sharpless NE: Ink4a/Arf links senescence and aging. Exp Gerontol 39:1751-1759, 2004 (Pubitemid 39576145)
22. Krishnamurthy J, Torrice C, Ramsey MR, et al: Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114:1299-1307, 2004 (Pubitemid 40385301)
23. Munro J, Barr NI, Ireland H, et al: Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. Exp Cell Res 295:525-538, 2004 (Pubitemid 38490504)
24. Liu Y, Johnson SM, Fedoriw Y, et al: Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes. Blood 117:3257-3267, 2011
25. Holst CR, Nuovo GJ, Esteller M, et al: Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res 63:1596-1601, 2003 (Pubitemid 36373649)
26. Kirkwood TB, Holliday R: The evolution of ageing and longevity. Proc R Soc Lond B Biol Sci 205:531-546, 1979 (Pubitemid 10248039)
27. Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 25:585-621, 1961
28. Giraud-Panis MJ, Pisano S, Benarroch-Popivker D, et al: One identity or more for telomeres? Front Oncol 3:48, 2013
29. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, et al: A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:194-198, 2003 (Pubitemid 37442589)
30. Gilson E, Géli V: How telomeres are replicated. Nat Rev Mol Cell Biol 8:825-838, 2007 (Pubitemid 47462137)
31. Prieur A, Peeper DS: Cellular senescence in vivo: A barrier to tumorigenesis. Curr Opin Cell Biol 20:150-155, 2008
32. Collado M, Serrano M: Senescence in tumours: Evidence from mice and humans. Nat Rev Cancer 10:51-57, 2010
33. Xue W, Zender L, Miething C, et al: Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656-660, 2007 (Pubitemid 46232886)
34. Kang TW, Yevsa T, Woller N, et al: Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479:547-551, 2011
35. Peeper DS: Ageing: Old cells under attack. Nature 479:186-187, 2011
36. Feldser DM, Greider CW: Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 11:461-469, 2007 (Pubitemid 46670077)
37. Cosme-Blanco W, Shen MF, Lazar AJ, et al: Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep 8:497-503, 2007 (Pubitemid 46696521)
38. Zhu J, Wang H, Bishop JM, et al: Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci U S A 96:3723-3728, 1999 (Pubitemid 29168977)
39. Biroccio A, Cherfils-Vicini J, Augereau A, et al: TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells. Nat Cell Biol 15:818-828, 2013
40. DeGregori J: Evolved tumor suppression: Why are we so good at not getting cancer? Cancer Res 71:3739-3744, 2011
41. Gosselin K, Martien S, Pourtier A, et al: Senescence-associated oxidative DNA damage promotes the generation of neoplastic cells. Cancer Res 69:7917-7925, 2009
42. Cypser JR, Johnson TE: Multiple stressors in Caenorhabditis elegans induce stress hormesis and extended longevity. J Gerontol A Biol Sci Med Sci 57:B109-B114, 2002 (Pubitemid 34202931)
43. Chang BD, Swift ME, Shen M, et al: Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci U S A 99:389-394, 2002 (Pubitemid 34060371)
44. Zhang H, Pan KH, Cohen SN: Senescencespecific gene expression fingerprints reveal celltype-dependent physical clustering of up-regulated chromosomal loci. Proc Natl Acad Sci U S A 100: 3251-3256, 2003 (Pubitemid 36356569)
45. Parrinello S, Coppe JP, Krtolica A, et al: Stromal-epithelial interactions in aging and cancer: Senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 118:485-496, 2005 (Pubitemid 40310116)
46. Bavik C, Coleman I, Dean JP, et al: The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 66:794-802, 2006 (Pubitemid 43165944)
47. Coppé JP, Patil CK, Rodier F, et al: Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6:2853-2868, 2008
48. Kuilman T, Peeper DS: Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 9:81-94, 2009
49. Coppé JP, Desprez PY, Krtolica A, et al: The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu Rev Pathol 5:99-118, 2010
50. Krtolica A, Parrinello S, Lockett S, et al: Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc Natl Acad Sci U S A 98:12072-12077, 2001 (Pubitemid 32959828)
51. Liu D, Hornsby PJ: Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res 67:3117-3126, 2007 (Pubitemid 46724848)
52. Ju Z, Jiang H, Jaworski M, et al: Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment. Nat Med 13:742-747, 2007 (Pubitemid 46889751)
53. Wang J, Sun Q, Morita Y, et al: A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage. Cell 148:1001-1014, 2012
54. Trumpp A, Essers M, Wilson A: Awakening dormant haematopoietic stem cells. Nat Rev Immunol 10:201-209, 2010
55. Sancho E, Batlle E, Clevers H: Live and let die in the intestinal epithelium. Curr Opin Cell Biol 15:763-770, 2003 (Pubitemid 37487970)
56. Schepers AG, Snippert HJ, Stange DE, et al: Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337:730-735, 2012
57. Snippert HJ, Schepers AG, van Es JH, et al: Biased competition between Lgr5 intestinal stem cells driven by oncogenic mutation induces clonal expansion. EMBO Rep 15:62-69, 2014
58. Vaziri H, Dragowska W, Allsopp RC, et al: Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci U S A 91:9857-9860, 1994 (Pubitemid 24311907)
59. Rossi DJ, Seita J, Czechowicz A, et al: Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle 6:2371-2376, 2007 (Pubitemid 350058690)
60. Rübe CE, Fricke A, Widmann TA, et al: Accumulation of DNA damage in hematopoietic stem and progenitor cells during human aging. PLoS One 6:e17487, 2011
61. TeKippe M, Harrison DE, Chen J: Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice. Exp Hematol 31:521-527, 2003 (Pubitemid 36793959)
62. Berfield AK, Andress DL, Abrass CK: IGFBP- 5(201-218) stimulates Cdc42GAP aggregation and filopodia formation in migrating mesangial cells. Kidney Int 57:1991-2003, 2000 (Pubitemid 30252291)
63. Chen J, Ellison FM, Keyvanfar K, et al: Enrichment of hematopoietic stem cells with SLAM and LSK markers for the detection of hematopoietic stem cell function in normal and Trp53 null mice. Exp Hematol 36:1236-1243, 2008
64. Dumble M, Moore L, Chambers SM, et al: The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood 109:1736-1742, 2007 (Pubitemid 46239609)
65. Matheu A, Maraver A, Klatt P, et al: Delayed ageing through damage protection by the Arf/p53 pathway. Nature 448:375-379, 2007 (Pubitemid 47080339)
66. Wilson A, Laurenti E, Trumpp A: Balancing dormant and self-renewing hematopoietic stem cells. Curr Opin Genet Dev 19:461-468, 2009
67. Conboy IM, Rando TA: Aging, stem cells and tissue regeneration: Lessons from muscle. Cell Cycle 4:407-410, 2005 (Pubitemid 41359725)
68. Bondar T, Medzhitov R: p53-mediated hematopoietic stem and progenitor cell competition. Cell Stem Cell 6:309-322, 2010
69. Porter CC, Baturin D, Choudhary R, et al: Relative fitness of hematopoietic progenitors influences leukemia progression. Leukemia 25:891-895, 2011
70. Gems D, Doonan R: Antioxidant defense and aging in C. elegans: Is the oxidative damage theory of aging wrong? Cell Cycle 8:1681-1687, 2009
71. Gems D, de la Guardia Y: Alternative perspectives on aging in Caenorhabditis elegans: Reactive oxygen species or hyperfunction? Antioxid Redox Signal 19:321-329, 2013
72. Fontana L, Meyer TE, Klein S, et al: Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A 101:6659-6663, 2004 (Pubitemid 38586030)
73. Meyer TE, Kovács SJ, Ehsani AA, et al: Longterm caloric restriction ameliorates the decline in diastolic function in humans. J Am Coll Cardiol 47:398-402, 2006 (Pubitemid 43063261)
74. Blagosklonny MV: Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program. Cell Cycle 9:3151-3156, 2010
75. Blagosklonny MV: Answering the ultimate question "what is the proximal cause of aging?" Aging 4:861-877, 2012
76. Berman AE, Leontieva OV, Natarajan V, et al: Recent progress in genetics of aging, senescence and longevity: Focusing on cancer-related genes. Oncotarget 3:1522-1532, 2012
77. Harding C, Pompei F, Wilson R: Peak and decline in cancer incidence, mortality, and prevalence at old ages. Cancer 118:1371-1386, 2012
78. Leng SX, Cappola AR, Andersen RE, et al: Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 16:153-157, 2004 (Pubitemid 38714057)